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Background: Inadequacy in mental health care in low and middle income countries has been an important
contributor to the rising global burden of disease. The treatment gap is salient in resource-poor settings, especially
when providing care for conflict-affected forced migrant populations. Primary care is often the only available service
option for the majority of forced migrants, and integration of mental health into primary care is a difficult task. The
proposed pilot study aims to explore the feasibility of integrating mental health care into primary care by providing
training to primary care practitioners serving displaced populations, in order to improve identification, treatment,
and referral of patients with common mental disorders via the World Health Organization Mental Health Gap Action
Programme (mhGAP).
Methods/Design: This pilot randomized controlled trial will recruit 86 primary care practitioners (PCP) serving in
the Puttalam and Mannar districts of Sri Lanka (with displaced and returning conflict-affected populations). The
intervention arm will receive a structured training program based on the mhGAP intervention guide. Primary
outcomes will be rates of correct identification, adequate management based on set criteria, and correct referrals of
common mental disorders. A qualitative study exploring the attitudes, views, and perspectives of PCP on integrating
mental health and primary care will be nested within the pilot study. An economic evaluation will be carried out by
gathering service utilization information.
Discussion: In post-conflict Sri Lanka, an important need exists to provide adequate mental health care to
conflict-affected internally displaced persons who are returning to their areas of origin after prolonged displacement.
The proposed study will act as a local demonstration project, exploring the feasibility of formulating a larger-scale
intervention study in the future, and is envisaged to provide information on engaging PCP, and data on training
and evaluation including economic costs, patient recruitment, and acceptance and follow-up rates. The study
should provide important information on the WHO mhGAP intervention guide to add to the growing evidence
base of its implementation.
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Inadequacy in mental health care in low and middle
income countries (LMIC) has been an important contribu-
tor to the rising global burden of disease [1]. The treatment
gap in mental health in LMIC has been well researched,
and a strong evidence base is rapidly building through
numerous epidemiological and interventional studies in
resource-poor settings [2,3]. The importance of incorporating
mental health care into existing primary care systems in
LMIC has been recognized as a priority by global health
policymakers such as the World Health Organization
(WHO), global leaders in mental health research, and
national governments of LMIC [4-6]. Scaling up of primary
care services and task-shifting approaches have been
recognized as key concepts in integrating mental health
with primary care provision in resource-poor settings [7,8].
Common mental disorders (CMD) are a broad spectrum
of conditions, which include depressive and anxiety
disorders [9]. They are predominantly present in primary
care settings, especially in LMIC [10,11]. However, low
detection or non-detection by primary health care providers,
increased rates of symptomatic treatment, low referral
rates for specialist care, and increased healthcare costs are
all associated with CMD in primary care settings in LMIC
[10,12]. Lack of adequate training for primary care
physicians, lack of adequate human resources (number
of physicians), inadequate health systems, and lack of
adequate policy attention are seen as the main barriers to
effective treatment of CMD through integrating mental
health into primary care in LMIC [10,11,13].
In conflict-affected situations, existing resource-limited
health systems can be severely affected, limiting any
provision of care to populations; this is especially salient
for forced migrants in LMIC [14]. Mental health care may
be considered a secondary consideration in post-conflict
settings, where primary care resources are usually allocated
for more immediate health concerns [15,16]. However,
there is strong evidence that conflict-driven forced migrants
have increased rates of mental disorders including CMD
and post-traumatic stress disorder [17,18]. Primary care,
however limited, is often the only available service op-
tion for the majority of forced migrants, except for those
refugees who manage to migrate to more resourceful
countries or regions. Integration of mental health into
primary care for conflict-affected forced migrants is
adifficult task given the political, cultural, economic,
and security complications involved. However, there is
some evidence that such integration is feasible even in
difficult settings, with the potential to improve mental
health of affected populations [19].
Although it is recognized that Sri Lanka has a very
effective primary care system, the primary care treatment
gap for mental health is extensive [20]. Owing to the
recently concluded three-decade conflict, the country hasseveral resource-poor regions where there are forced
internal migrants, with some having lived in prolonged
displacement for over 20 years, and return migration
having only recently started. Populations of internally
displaced persons (IDP) who experienced prolonged forced
migration in Sri Lanka have shown increased rates of
CMD (18.8%) compared with national figures, especially
of somatoform disorders (14% compared with a national
prevalence of 4.2%) and major depression (5.1% compared
with a national prevalence of 2.6%), and they lack adequate
services of specialist mental health care providers, including
psychiatrists [18,20,21]. This is evident among the northern
Muslim IDP, displaced as a result of conflict in 1990 in the
northern province (mainly Mannar district), who have
been living in displacement in the Puttalam district of the
north-western province, and are currently returning to
areas of origin [18]. Return migration areas in the Mannar
district in particular lack adequate healthcare facilities to
cater for the influx of returnee populations. For those IDP
opting to live in Puttalam, available mental health services
are also limited, and the Puttalam district did not have the
services of a psychiatrist until 2008. Although the Ministry
of Health has taken steps to train a new category of
Medical Officers of Mental Health (MOMH) to provide
increased mental health care in the absence of specialist
psychiatrists, their services are also insufficient to match
the existing healthcare needs. Primary care physicians, such
as general practitioners, medical officers in government
primary care facilities, and medical officers in tertiary care
outpatient departments located in the Puttalam or Mannar
districts are the front line and often the only available
option for mental health care of IDP. However, these
physicians do not have the adequate training or skills to
identify and treat mental disorders in the busy primary
care setting in which they work.
Against this background, the proposed pilot study
titled "An intervention to improve mental health care for
conflict-affected forced migrants in low-resource primary
care settings: a WHO MhGAP-based pilot study in Sri
Lanka (COM-GAP)" aims to integrate mental health
care into primary care by providing training to primary
care practitioners (PCP) serving populations of IDP to
improve identification, treatment, and referral of patients
with CMD via the WHO Mental Health Gap Action
Programme (mhGAP). The mhGAP initiative, introduced
in 2008 by the WHO, incorporates evidence-based guide-
lines on managing mental, neurological, and substance
abuse disorders in the primary care setting by non-
specialist healthcare workers [7,22]. The mhGAP Inter-
vention Guide (mhGAP IG), introduced in 2010, is a
valuable manual that can be used as a resource in training
non-specialists in primary mental health care, and is
currently in its evaluation and implementation stage in
several countries [7,8].
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assess the feasibility of improving/increasing identification,
treatment, and referral of CMD by PCP working with a
group of displaced and returning forced migrants in a
resource-poor, rural, primary care setting via a training
program based on the WHO mhGAP IG. This will be
carried out by developing a pilot randomized controlled
trial (ACT) in the north and north-western provinces
of Sri Lanka. The main hypothesis of the study is that
training intervention using mhGAP IG will increase
rates of correct identification, treatment, and specialist
referral rates of the PCP. It is envisaged that training
PCP to efficiently identify, treat, and refer patients with
CMD will reduce the acute and long-term disease burden,
reduce service-provision costs, and provide effective/
accessible mental health care to vulnerable/traumatized
IDP. As South Asia faces continuous problems relating to
mass forced migration, this study may provide important
evidence on reducing the treatment gap for vulnerable
populations in the region, with a high potential for scaling
up in other resource-poor settings. This is the first study
of its kind to be undertaken in Sri Lanka, and is planned
as a local demonstration study to aid a future larger-scale
intervention.Methods/design
Study design and setting
The study will be carried out in primary care settings
(outpatient departments of government hospitals, govern-
ment rural hospitals, government central dispensaries, and
private medical clinics) in the Puttalam and Mannar
districts of the north and north-western provinces of Sri
Lanka, where conflict-affected, long-term displaced/return-
ing migrants are located. It will be conducted as a feasibility
study in the form of a pilot RCT.Participants
Two groups of participants will be recruited. The main
participant group will be PCP working in government
health services or private practices in the primary care
institutions listed above within the geographical areas
of the Puttalam and Mannar districts. The secondary
participant group will be patients diagnosed with CMD
(depression, anxiety, somatoform disorder/medically un-
explained symptoms, or suicidal ideation) by the recruited
PCP during the study period. PCP will be approached at
the primary care institutions (government and/or private)
by the principal investigator (PI) and the research team.
They will also be approached (as applicable) through the
Sri Lanka College of General Practitioners and other
relevant organizations. Appropriate permission has been
sought and obtained from the Ministry of Health and
Provincial Ministries of Health.Inclusion and exclusion criteria
To be included, PCP will need to: have 5 or more years
of experience, have full registration with the Sri Lankan
Medical Council, and be providing a minimum of 4 hours/
day of primary care to IDP populations. PCP will be
excluded if: they are psychiatrists, have secondary mental
health training, less than 5 years of service, and work less
than 4 hours/day with IDP populations.
To be included, patients will need to: belong to a specific
IDP groups, and be adult (18 years or older). Patients aged
under 18 years will be excluded, as the intervention training
focuses on adult population. Patients diagnosed with
serious mental disorders will also be excluded as the inter-
vention training focus is on CMD.
Sampling
It must be highlighted that this is purely a feasibility study.
Therefore, as a pilot RCT, 43 PCP for each arm (total of
86) are estimated to be a sufficient sample size, including
drop-out allowance [23,24]. Specific global evidence
required for sample size calculation through standard
methods is not available. Sample size calculations for
patients are not required, as they will not be included
in the trial, and no outcomes will be measured for this
group (more details explained in the next section).
Intervention
The training intervention will be based on the mhGAP IG
developed by the WHO. Only relevant modules (depres-
sion, medically unexplained symptoms, alcohol abuse, and
suicide) will be used for the training. The training will be
based on a complete training guide and material provided
by the WHO, which contains the necessary course material
for trainees and preparatory and guidance materials for
trainers. It will be conducted by the PI (who has been
trained by the Royal College of Psychiatrists affiliated
mhGAP training programme, UK), mhGAP IG experts,
and another clinically experienced psychiatrist. Training
programs will be conducted as a full-day course for five
consecutive days, as originally designed by the WHO. The
training intervention will be given to 43 (approximately
half ) of the recruited PCP in the intervention arm, ran-
domized by appropriate techniques. Participants in the
control arm will be given a similar training in mhGAP
after the completion of the study.
Training will take place after an initial 3 month mon-
itoring period of the whole sample from the date of
recruitment (90 day monitoring period for each participant
from the date of recruitment). During this period, all PCP
are required to inform the study coordinator immediately
on diagnosing a primary care patient with CMD. The PCP
is required to obtain written informed consent from each
patient if they agree to be contacted by the research team,
prior to informing the coordinator. All PCP will be given
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prior to commencing the study.
After the 5 day training period of the intervention
group, both arms will be monitored again for a 3 month
period. Those in the intervention arm will be required
to use the mhGAP guide to diagnose, treat, and refer
patients with possible mental health problems whom
they encounter in their respective primary care settings.
The control arm will be requested to continue their
existing diagnostic and treatment practices. Participants
in both arms will be required to communicate any CMD
diagnoses to the study coordinator immediately.
During the first and second 3-month monitoring
periods, the study coordinator will gather a list of patients
diagnosed by the participant PCP (from both intervention
and control arms) on a daily and weekly basis. These
patients will then be approached individually by the study
coordinator, who will explain the purpose of the study.
The coordinator will provide an information leaflet and
obtain secondary written consent from each patient.
Consenting patients will then be directed to the study
psychiatrist, who will reassess them according to mhGAP-
based criteria for concurrence with the initial PCP diagnosis.
Unless absolutely necessary, the psychiatrist will not
modify or change the treatment or management outlined
by the PCP. For those patients categorized as referrals to
specialist care, their treatment and management will be
provided by the study psychiatrist. However, referral
patients will be completely free to decide if they want
to be treated by the study psychiatrist or to seek care
from other government or private specialist psychiatrists.
All patients consenting to be involved in the study will be
compensated for travelling costs or provided with travel
if they prefer. No other compensation will be offered.
For COM-GAP study phases according to CONSORT
guidelines, please see the Additional file 1.
Randomization allocation
All PCP recruited to the study will be randomized into the
intervention and control arms by the study statistician
using standard randomization techniques. It is not neces-
sary to randomized the the patients.
Allocation concealment
It will not be possible to mask the study team to the status
of the PCP, as they will be aware of the PCP participants
in the training intervention arm. The study psychiatrist
will be blinded/masked to the randomization status of the
PCP, and therefore be unbiased with regard to the patients
originating from each PCP (that is, whether a patient was
diagnosed by a trained or untrained PCP). The study
psychiatrist will therefore not be involved in the training
program. In addition, patients will also be blinded to the
PCP randomization status.Minimization of contamination
The PCP will be working in close, possibly overlapping
geographical locations, thus there is a theoretical possibility
of contamination by recruits having personal knowledge
of each other. Additionally, there is a possibility of PCP in
different study groups exchanging information received in
the training. While we acknowledge that such interaction
may potentially lead to contamination, it should be noted
that this will be extremely difficult to prevent, and is not
likely have a significant influence on the outcome. Because
the training provided during the study is very thorough,
and the study group participants are required to carry
out intensive tasks, contamination through exchanges of
information in informal discussions is not anticipated.
However, as a preventive action, both the study and
control group PCPs will be requested to refrain from
seeking study-related information from each other for
the duration of the intervention. At all possible times
during recruitment, training, and monitoring, steps will be
taken to observe potential contamination. At the end of
the study, information will be gathered separately from
both groups in order to gain an insight into potential
contamination. However, it must be mentioned that, as
this is a feasibility pilot study, minor contamination may
not affect the outcomes to a large degree.
Measurements
A sociodemographic questionnaire will be administered
to all PCP, and this will include a section on medical
education and experience at the point of recruitment. At
baseline, PCP will also be given knowledge assessment
questionnaires on each module included in the intervention
training, to measure their existing knowledge. This will
be repeated for the intervention arm during the training
program at the start of each module. The knowledge-
assessment questions to be used have been designed by
the WHO to match the mhGAP training package. The
same measure will be given to the control arm (without
the training) at the same timepoint as the intervention
arm. Post-training knowledge assessments (designed by
the WHO) will be administered to the intervention arm at
the end of the 5 day training program, and to the control
arm at the same time. For both arms, knowledge assess-
ment will be repeated at the end of the study period.
All patients who consent to participate will be given a
sociodemographic questionnaire. At the point of recruit-
ment, they will also be given an appropriate language
version of the Patient Health Questionnaire (PHQ) as a
screening measure [25]. The PHQ has been translated
and used in both Sinhala and Tamil languages in the
Sri Lankan IDP population [18]. The final instrument
administered to patients will be the Sri Lankan version
of the Client Service Receipt Inventory (CSRI) [26-28] to
record health service utilization, including time lost from
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point of recruitment and after the 3 month follow-up
period.
Primary outcomes and statistical analysis
Referral rates before and after the intervention will be
measured for all PCP. Rates of study psychiatrist-verified
diagnoses will be measured. Quality of adherence to
mhGAP guidelines for treatment and management will
be assessed for the intervention arm. Knowledge levels
at the three test points will be measured for all PCP.
For PCP in the intervention arm, knowledge levels will
be assessed during each day of the training program.
Overall comparisons will be made between the intervention
and control arm rates for referral, correct diagnosis, and
knowledge increase. Secondary outcomes include concur-
rence between the clinical diagnosis and the screening in-
strument and basic economic evaluation (described later).
No interim analysis will be carried out, and analysis
will commence only at the end of the full study period.
Because this is a pilot study, the analysis will be focused
on primary feasibility, and therefore will primarily be
descriptive in nature, with estimations of confidence
intervals as appropriate [24]. As power calculations will
not be carried out, it would not be appropriate to conduct
analyses aimed at testing hypotheses [24]. The main
analysis will be based on difference in outcomes of
intervention and control arms using two-way analysis
of variance (ANOVA). Appropriate consideration will
be given to potential confounders. Results will be used to
formulate sample size calculation for a larger intervention.
Data management and trial procedures
Double data entry will be conducted by a team of data
entry operators blinded to details of allocation. A statisti-
cian and a data manager will supervise the data entry
process. The PI will be responsible for the overall manage-
ment and supervision of the study. The PI has previous
experience as a clinical trial monitor for an international
clinical trial, and has been fully trained in Good Clinical
Practice (GCP) guidelines. He is trained to deliver the
mhGAP course by the Royal College of Psychiatrists in the
UK. He has also conducted two large-scale epidemio-
logical surveys of the IDP population in the Puttalam and
Mannar districts, and has built a high level of rapport
with the communities. The study will be coordinated by a
medically trained researcher with previous coordination
experience. The coordinator will be responsible for liaising
with PCP, recruiting PCP and patients, and coordinating
the patient referrals to the study psychiatrist. The study
psychiatrist has experience in working with clinical
populations in Sri Lanka for a number of years. The
overall supervision of the study will be performed by a
highly experienced consultant psychiatrist with extensiveresearch and clinical experience in both Sri Lanka and
the UK.
Qualitative component
A small-sample qualitative study nested within the pilot
RCT will be carried out to explore the attitudes and per-
spectives of PCP on the importance of integrating mental
health into primary care. The qualitative component
will be carried out prior to the main study in order to
provide feedback for the training intervention. Participants
(approximately 20) will be recruited from within the
main study PCP cohort. Informed written consent will
be obtained separately for the qualitative component. An
in-depth individual interview based on a topic guide will
be conducted by a trained qualitative researcher to elicit
views, perceptions, and attitudes of PCP towards mental
health, importance of providing mental health care,
integration of mental health into primary care settings,
perceived barriers and requirements for such initiatives,
and other related topics. All interviews will be conducted
in English, at a location preferred and convenient to par-
ticipants, and audio-recorded with consent. Maximum
confidentiality will be assured throughout the process of
recruitment, interview, and subsequent analysis. Audio
recordings will be transcribed verbatim, and subsequently
analyzed using the thematic analysis model.
Economic evaluation
The study will calculate the costs incurred in training
the PCP in mental health care, and the extra time they
may spend with patients. These costs will be linked to
the primary outcome measure in order to determine the
extra cost incurred to detect one extra patient. Other
service use data (primary care, secondary care, social
care, input from families) will be recorded through the
CSRI for patients identified with CMDs, and costs will
be calculated using unit costs specific to Sri Lanka.
These costs will be added to the intervention costs, and
will be compared with information from other more
resource-rich populations to understand the economic
implications of service provision to vulnerable populations.
The number of patients receiving treatment will be
identified, and the disability adjusted life years (DALYs)
calculated. The cost per DALY avoided will subsequently
be calculated. Research findings have shown that higher
rates of CMD are associated with unemployment in IDP
populations in the region, and economic evaluations of
mental health care interventions provide important infor-
mation for IDP management and service provision [18].
Ethical issues
Ethics approval has been obtained from the Ethics Review
Committee, Faculty of Medical Sciences, University of
Sri Jayewardenepura, Sri Lanka. Informed written consent
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and an information leaflet will be provided to them. An
appropriate length of time (minimum 1 day) will be
allowed for decision-making. If the PCP is interested,
the study coordinator will obtain their written consent.
Each patient diagnosed by individual PCP during study
period will be asked twice for consent. In first instance,
the PCP will explain the study and obtain consent from
the patient for the study team to approach the patient.
The patient will be told that the treatment will strictly
not depend on their decision to participate. PCP will be
trained in ethical aspects of informed consent, and will
be strongly encouraged to prevent undue inducement or
coercion. However, given the doctor-patient relationship
in Sri Lanka, this is extremely difficult to prevent. The
study team will make regular spot-checks with PCP to
ensure that systematic coercion is not present. If a patient
consents to be approached by the study team, then the
study coordinator will approach the patient and re-explain
the study with an information leaflet. Again, after an
appropriate time gap, the patient will be asked to decide
to participate. If they consent, the study coordinator will
make subsequent arrangements for the patient to have a
clinical interview with the study psychiatrist. From the
moment of recruitment, all patients will be anonymized to
the study team, and data will be entered using a numbered
coding system. Both PCP and patients will be explicitly
informed of the feasibility nature of the pilot study during
the recruitment process. Both PCP and patients will be
able to withdraw at any time during the study without
presenting a reason. Maximum efforts will be made to
ensure data protection and confidentiality. If the study
psychiatrist discovers significant medical errors in the
treatment and management by PCP, they will be indi-
vidually approached and advised to rectify the errors. As
mentioned above, referral patients have the choice to
refuse the services of the study psychiatrist and seek
specialist care elsewhere. If any serious mental disorders
are diagnosed by the PCP during the study period, those
patients will be advised to seek immediate specialist
advice and refer to specialist care. The study team will
provide full support in such situations, both to the PCP
and the patient, as required. Information leaflets and
consent forms for PCP will be in English, and for patients
they will also be available in Sinhala and Tamil.
Ethics approval
The study has been approved by the Ethics Review
Committee, Faculty of Medical Sciences, University of Sri
Jayewardenepura, Sri Lanka.
Discussion
The main purpose of this feasibility study is to integrate
mental health into primary health care by training PCPto improve identification, management, and referral of
CMD for conflict-affected forced migrants. In post-conflict
Sri Lanka, an important need exists to provide adequate
mental health care to conflict-affected IDP returning to
their area of origin after prolonged displacement. The
proposed study will act as a local demonstration project
exploring the feasibility of formulating a larger-scale
intervention study in the future, and is envisaged to provide
information on PCP engagement, training and evaluation,
and rates of patient recruitment, acceptance, and follow-up.
It is also planned to measure the views, attitudes, and
perceptions of PCP on integrating mental health in to
primary care. The economic evaluation is aimed at collating
information about the costs involved in obtaining and
providing mental health care in resource-poor primary care
settings, which will aid policy decisions on management of
IDP and other vulnerable populations. The study stands to
provide important information on the WHO mhGAP
intervention guide to add to the growing evidence base
of its implementation, which will be helpful to tailor it
to training primary care workers in other global
conflict-affected populations and humanitarian contexts.
Trial status
Commenced.
Additional file
Additional file 1: Consolidated Standards of Reporting Trials
(CONSORT) flow diagram for COM-GAP study phases.
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